Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among italian health care professionals

Carla Colombo, Paola Catastini, Anna Brivio, Benedetto Acone, Patricia Dang, Serena Quattrucci

Research output: Contribution to journalArticle

Abstract

Purpose: The aim of this study was to determine the level of consensus among Italian health care professionals (HCPs) regarding factors that influence adherence to cystic fibrosis (CF) treatments. Methods: A Delphi questionnaire with 94 statements of potential factors influencing adherence was developed based on a literature review and in consultation with a board of experts (n=4). This was distributed to a multidisciplinary expert panel of HCPs (n=110) from Italian CF centers. A Likert scale was used to indicate the level of agreement (1= no agreement to 9= maximum agreement) with each statement. Three rounds were distributed to establish a consensus (≥80% of participant ratings within one 3-point region) and, at the third round, assign a ranking to each statement with a high level of agreement (consensus in the 7–9 range) only. Results: Of 110 HCPs (from 31 Italian CF centers who were surveyed), responses were obtained from 85 (77%) in the first, 78 (71%) in the second, and 72 (65%) in the third round. The highest degree of agreement (95.8%) was reached with the statement that the HCP needs to build a relationship with the patient to influence adherence. A high level of agreement was not reached for statements that morbidity and mortality are influenced by the level of adherence to therapy, and no consensus was reached on the statement that age of the patient influences adherence to treatment. Conclusion: We found that Italian HCPs endorsed a strong relationship with the patient as being a key driver in improving adherence. There were several areas, such as the influence of adherence on morbidity and mortality, where the consensus of Italian HCPs differed from the published literature. These areas require investigation to determine why these discrepancies exist.

Original languageEnglish
Pages (from-to)2233-2241
Number of pages9
JournalPatient Preference and Adherence
Volume12
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Cystic Fibrosis
health care
Consensus
Delivery of Health Care
morbidity
Therapeutics
mortality
expert
Morbidity
Mortality
Patient Compliance
ranking
Referral and Consultation
rating
driver
questionnaire

Keywords

  • Cystic fibrosis
  • Delphi technique
  • Long-term adherence

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Social Sciences (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy

Cite this

Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among italian health care professionals. / Colombo, Carla; Catastini, Paola; Brivio, Anna; Acone, Benedetto; Dang, Patricia; Quattrucci, Serena.

In: Patient Preference and Adherence, Vol. 12, 01.01.2018, p. 2233-2241.

Research output: Contribution to journalArticle

Colombo, Carla ; Catastini, Paola ; Brivio, Anna ; Acone, Benedetto ; Dang, Patricia ; Quattrucci, Serena. / Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among italian health care professionals. In: Patient Preference and Adherence. 2018 ; Vol. 12. pp. 2233-2241.
@article{c1de6f908336410aad1c17b5c89077e0,
title = "Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among italian health care professionals",
abstract = "Purpose: The aim of this study was to determine the level of consensus among Italian health care professionals (HCPs) regarding factors that influence adherence to cystic fibrosis (CF) treatments. Methods: A Delphi questionnaire with 94 statements of potential factors influencing adherence was developed based on a literature review and in consultation with a board of experts (n=4). This was distributed to a multidisciplinary expert panel of HCPs (n=110) from Italian CF centers. A Likert scale was used to indicate the level of agreement (1= no agreement to 9= maximum agreement) with each statement. Three rounds were distributed to establish a consensus (≥80{\%} of participant ratings within one 3-point region) and, at the third round, assign a ranking to each statement with a high level of agreement (consensus in the 7–9 range) only. Results: Of 110 HCPs (from 31 Italian CF centers who were surveyed), responses were obtained from 85 (77{\%}) in the first, 78 (71{\%}) in the second, and 72 (65{\%}) in the third round. The highest degree of agreement (95.8{\%}) was reached with the statement that the HCP needs to build a relationship with the patient to influence adherence. A high level of agreement was not reached for statements that morbidity and mortality are influenced by the level of adherence to therapy, and no consensus was reached on the statement that age of the patient influences adherence to treatment. Conclusion: We found that Italian HCPs endorsed a strong relationship with the patient as being a key driver in improving adherence. There were several areas, such as the influence of adherence on morbidity and mortality, where the consensus of Italian HCPs differed from the published literature. These areas require investigation to determine why these discrepancies exist.",
keywords = "Cystic fibrosis, Delphi technique, Long-term adherence",
author = "Carla Colombo and Paola Catastini and Anna Brivio and Benedetto Acone and Patricia Dang and Serena Quattrucci",
year = "2018",
month = "1",
day = "1",
doi = "10.2147/PPA.S172222",
language = "English",
volume = "12",
pages = "2233--2241",
journal = "Patient Preference and Adherence",
issn = "1177-889X",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among italian health care professionals

AU - Colombo, Carla

AU - Catastini, Paola

AU - Brivio, Anna

AU - Acone, Benedetto

AU - Dang, Patricia

AU - Quattrucci, Serena

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: The aim of this study was to determine the level of consensus among Italian health care professionals (HCPs) regarding factors that influence adherence to cystic fibrosis (CF) treatments. Methods: A Delphi questionnaire with 94 statements of potential factors influencing adherence was developed based on a literature review and in consultation with a board of experts (n=4). This was distributed to a multidisciplinary expert panel of HCPs (n=110) from Italian CF centers. A Likert scale was used to indicate the level of agreement (1= no agreement to 9= maximum agreement) with each statement. Three rounds were distributed to establish a consensus (≥80% of participant ratings within one 3-point region) and, at the third round, assign a ranking to each statement with a high level of agreement (consensus in the 7–9 range) only. Results: Of 110 HCPs (from 31 Italian CF centers who were surveyed), responses were obtained from 85 (77%) in the first, 78 (71%) in the second, and 72 (65%) in the third round. The highest degree of agreement (95.8%) was reached with the statement that the HCP needs to build a relationship with the patient to influence adherence. A high level of agreement was not reached for statements that morbidity and mortality are influenced by the level of adherence to therapy, and no consensus was reached on the statement that age of the patient influences adherence to treatment. Conclusion: We found that Italian HCPs endorsed a strong relationship with the patient as being a key driver in improving adherence. There were several areas, such as the influence of adherence on morbidity and mortality, where the consensus of Italian HCPs differed from the published literature. These areas require investigation to determine why these discrepancies exist.

AB - Purpose: The aim of this study was to determine the level of consensus among Italian health care professionals (HCPs) regarding factors that influence adherence to cystic fibrosis (CF) treatments. Methods: A Delphi questionnaire with 94 statements of potential factors influencing adherence was developed based on a literature review and in consultation with a board of experts (n=4). This was distributed to a multidisciplinary expert panel of HCPs (n=110) from Italian CF centers. A Likert scale was used to indicate the level of agreement (1= no agreement to 9= maximum agreement) with each statement. Three rounds were distributed to establish a consensus (≥80% of participant ratings within one 3-point region) and, at the third round, assign a ranking to each statement with a high level of agreement (consensus in the 7–9 range) only. Results: Of 110 HCPs (from 31 Italian CF centers who were surveyed), responses were obtained from 85 (77%) in the first, 78 (71%) in the second, and 72 (65%) in the third round. The highest degree of agreement (95.8%) was reached with the statement that the HCP needs to build a relationship with the patient to influence adherence. A high level of agreement was not reached for statements that morbidity and mortality are influenced by the level of adherence to therapy, and no consensus was reached on the statement that age of the patient influences adherence to treatment. Conclusion: We found that Italian HCPs endorsed a strong relationship with the patient as being a key driver in improving adherence. There were several areas, such as the influence of adherence on morbidity and mortality, where the consensus of Italian HCPs differed from the published literature. These areas require investigation to determine why these discrepancies exist.

KW - Cystic fibrosis

KW - Delphi technique

KW - Long-term adherence

UR - http://www.scopus.com/inward/record.url?scp=85058784312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058784312&partnerID=8YFLogxK

U2 - 10.2147/PPA.S172222

DO - 10.2147/PPA.S172222

M3 - Article

AN - SCOPUS:85058784312

VL - 12

SP - 2233

EP - 2241

JO - Patient Preference and Adherence

JF - Patient Preference and Adherence

SN - 1177-889X

ER -